The 31st In Silico Megabank Research Seminar will be held on Monday, June 10.
This Time, we will be welcoming Dr. Toshitaka Odamaki, Food Science & Technology Institute, Morinaga Milk Industry Co., Ltd. as our lecturer, and he will be speaking on “The Anti-allergic Action by Bifidobacterium Administration.”

・Date/Time: June 10(Mon.) 16:00‐17:30
・Venue: Conference Room 1(2nd Floor), Tohoku Medical Megabank Organization http://www.megabank.tohoku.ac.jp/english/info/access.html
・Title: The Anti-allergic Action by Bifidobacterium Administration
・Lecturer: Toshitaka Odamaki (Food Science & Technology Institute, Morinaga Milk Industry Co., Ltd.)

・Abstract: Bifidobacterium is a kind of dominant bacterial species in the intestine, and various physiologies of it have been reported as “probiotics” as well as lactic acid bacterium. In the seminar, we will share the basic knowledge of bifidobacterium and introduce this focusing on two clinical tests that were confirmed with the anti-allergic action, namely, “Symptom relieving action of cedar pollen allergy for adults” and “Preventative action on the development of infant allergy by administration of bifidobacterium to pregnant women/infants” along with the analysis of the intestinal flora.

・Organizer: Masao Nagasaki